CLEVELAND, OH - You've heard plenty of things about Ohio Issue 2 from commercials to endorsements and oppositions. But just what will we be voting for or against next month?
The ballot language is about 100 words and essentially states, if approved, Ohio's state agencies will not pay more for prescription drugs than what the U.S. Department of Veterans Affairs pays.
"It only applies to drugs bought by the state government and are distributed under state programs, but two out of three Ohioans do not get their drugs through state programs", said Dale Butland, an opponent of Issue 2.
Butland says this is a national issue and addressing it state by state would only complicate things.
He's also against another aspect of the plan: if approved, the state would have to pay the attorney fees for those behind the new law to enforce it. Butland says taxpayers shouldn't have to pay for the lawyers of rich drug companies.
"The only way there would ever be any litigation is if the drug companies sue to prevent implementation in order to keep their drug prices as high as possible", said Former Ohio Republican Party Chairman Matt Borges, who supports Issue 2.
Borges says this is the chance for taxpayers to take prescription drug prices into their own hands and start paying less. He thinks it would be a wake-up call to state politicians.
This is the official ballot language for Issue 2:
"Require the State of Ohio, including its state departments, agencies and entities, to not pay more for prescription drugs than the price paid by the United States Department of Veterans Affairs. Establish that the individual petitioners responsible for proposing the law have a direct and personal stake in defending the law; require the State to pay petitioners' reasonable attorney fees and other expenses; require the petitioners to pay $10,000 to the State if the law is held by a court to be unenforceable and limit petitioners' personal liability to that amount; and require the Attorney General to defend the law if challenged in court."
(Photo by Getty Images)
© 2017 iHeartMedia, Inc.